Catechol estrogens and thrombosis: lack of a direct effect of 2-hydroxyestradiol on platelets.
Women who use the oral contraceptive pill are at risk for a variety of thromboembolic complications, but the precise mechanism is unclear. Since 2-hydroxyestradiol is a major metabolite of estradiol and possesses some of the structural and functional properties of catecholamines, we examined whether this compound might influence thrombogenesis, in particular whether it would exert an epinephrine-like effect on the platelet. In vitro, 2-hydroxyestradiol does not cause or potentiate aggregation or thromboxane release, nor does it prevent the rise in cyclic AMP caused by anti-aggregatory prostaglandins. While 2-hydroxyestradiol does not exert a direct effect on the platelet in vitro, it may play a role in thrombosis in women who take oral contraceptives through another mechanism.
D001792:Blood Platelets / Q000187:drug effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D004958:Estradiol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology; D013931:Thromboxanes / Q000378:metabolism
D003278:Contraceptives, Oral, Hormonal; D011458:Prostaglandins E; D013931:Thromboxanes; D004958:Estradiol; C001390:2-hydroxyestradiol; D000242:Cyclic AMP; D004837:Epinephrine